Sign in

CIK 0001868279 · Non-accelerated filer<br>Emerging growth company

ArriVent BioPharma, Inc.

Sign in to watch
Ticker
AVBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
240-780-6356
Business address
18 CAMPUS BLVD., SUITE 100, NEWTOWN SQUARE, PA, 19073-3269
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations · Executive or director change
  3. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  4. 4 Option exercise Chief Operating Officer acquired 40,693 shares (option exercise)
  5. 8-K Event Regulation FD disclosure · Other events
  6. 8-K Event Regulation FD disclosure
  7. SCHEDULE 13G Stake Statement of Beneficial Ownership
  8. 8-K Event Regulation FD disclosure · Other events
  9. SCHEDULE 13D/A Stake Beneficial Ownership Report
  10. 8-K Event Regulation FD disclosure · Other events
  11. 10-Q Report Quarterly Report
  12. 8-K Event Material agreement · Results of operations
  13. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 8-K Event Shareholder vote results
  19. 8-K Event Other events
  20. 424B5 Offering Prospectus

Page 1 of 9 · 162 filings